TVAX Biomedical (TVAX)

IPO News

3 US IPOs planned for the week of Feb 13 2/13/12
Caesars stands out in a busy pricing week with strong returns 2/10/12
10 U.S. IPOs planned for the week of Feb 6 2/6/12
Busy pricing period ahead after 7 companies set terms last week 1/30/12
TVAX Biomedical sets IPO terms, seeking $20 million 1/23/12
Biotech firm TVAX Biomedical files for a $40 million IPO 11/7/11

Performance History

Interested in IPO Investing?

Expected Date
Postponed
IPO File Date
11/07/11
Deal Size
$20.0 mm
Price Range
$9 - $11
Shares Offered
2.0 mm
We are not issuing research on this IPO.
Lead Manager(s)
Roth Capital
Co Manager(s)
Cantor Fitzgerald

All Underwriters

Business

Business
Biotech company focused on cancer cell vacination and T cell cancer treatment.
Industry
Health-Biomed/Genetics
Employees
6
Founded
2004

TVAX Daily

Chart

Corporate Data

Company Address
8006 Reeder Street
Lenexa, KS
Phone Number
(913) 492-2221
Web Address
www.tvaxbiomedical.com